In memory of Blue help us fund hemangiosarcoma research
Tax deductible
This incredibly handsome boy is Blue. He was a 4-year-old German Shorthaired Pointer. He loved his family, his baby brother, socks, and swimming at doggie daycare more than anything else in the world. He was known for his big heart. Unfortunately, his heart also had a tumor that there was no way to detect. Our Blue was his normal loving self until he wasn’t. He went from running around at Daycare one moment to not being able to get up in an instant. At the emergency vet they found a large pericardial effusion (a collection of blood or fluid around the heart) causing cardiac tamponade (compressing the heart so severely it cannot effectively pump blood to the body) and he needed to undergo an emergency procedure to evacuate the blood. Unfortunately, this was almost certainly caused by a dreadful type of cancer called Hemangiosarcoma. This continued to bleed, continued to cause heart arrhythmias, and as much as it pained us, we had to do the humane thing and say goodbye to our best friend Blue.
The “silent killer” hemangiosarcoma, the most aggressive cancer seen in all dogs, is a rapidly invasive tumor that arises on the spleen or right atrial appendage of the heart and is asymptomatic until it causes bleeding around the heart or spleen rupture. At that time, this largely incurable cancer is usually metastasized all over the body and even with invasive surgery and chemotherapy (of which tumors are usually resistant), prognosis is weeks to months. There have been no major advancements in treatment in over 30 years. Currently AKC Canine Health Fund is funding 6 research projects specifically targeting this tumor from early detection, genetic suppression, and novel new treatment options. We are raising money to benefit American Kennel Club Canine Health Foundation, and any donation will help make an impact. Thanks in advance for your contribution.
More information about American Kennel Club Canine Health Foundation: The mission of the American Kennel Club Canine Health Foundation, Inc. (CHF) is to advance the health of all dogs and their owners by funding scientific research and supporting the dissemination of health information to prevent, treat and cure canine disease.
- Investigating Volatile Organic Compounds as Potential Markers of Canine Hemangiosarcoma by Trained Bio-detection Dogs
- Suppression of Extracellular Glutamate Efflux & mGluR1 Signaling to Impede Canine Hemangiosarcoma Cell Growth
- A GD3 Nano-scaled Liposomal Cancer Vaccine Clinical Trial for Canine Hemangiosarcoma
- Towards Curative Outcomes in Canine Hemangiosarcoma
- Strategic Prevention of Canine Hemangiosarcoma: Lifetime Follow-Up
- Clinical Trial for Evaluation of Propranolol and Doxorubicin in the Treatment of Canine Hemangiosarcoma
Organizer
Michael R
Organizer
Nazareth, PA
American Kennel Club Canine Health Foundation
Beneficiary